The company is recalling the product because of out-of-specification results for high molecular weight polymers. Braun Medical Inc. (B. Braun) is voluntarily recalling one lot of 2g Ceftazidime for ...

Braun Medical Inc. (B. Braun) is voluntarily recalling one (1) lot of 2g Ceftazidime for Injection USP (2g) and Dextrose for Injection USP (50 ml) in Duplex® Container to the hospital/user level..

IRVINE, CA--(Marketwired - Mar 28, 2016) - B. Braun Medical Inc. is voluntarily recalling one lot of 5% Dextrose Injection USP 100/150mL container (Lot #J5J706, catalog # S5104-5264, NDC 0264-1510-32) ...

BETHLEHEM, PA--(Marketwired - Jul 8, 2015) - B. Braun Medical Inc. (B.Braun), a leader in infusion therapy and pain management, announced today that it has received FDA approval of 70% Dextrose for ...

FOR IMMEDIATE RELEASE – December 23, 2013 – Baxter International Inc. announced today it has initiated a voluntary recall to the hospital/user level of one lot of 5% Dextrose Injection, USP and four ...

Hospira announced a voluntary nationwide recall of one lot of Lactated Ringers and 5% Dextrose Injection, USP, 1000mL, Flexible Container. This recall is due to a confirmed customer report where a ...

April 8, 2004 — The FDA warned in February that dextrose injection USP (Excel, made by B. Braun Medical) contains aluminum that may reach toxic levels with prolonged parenteral administration in ...

B. Braun Medical Inc. of Irvine, CA is voluntarily recalling one lot of 5% Dextrose Injection USP 100/150mL container (Lot #J5J706, catalog # S5104-5264, NDC 0264-1510-32) to the consumer level. B.

FOR IMMEDIATE RELEASE - July 10, 2014 - Hospira, Inc. (NYSE: HSP), announced today it is initiating a voluntary nationwide user-level recall of one lot of Lactated Ringers and 5% Dextrose Injection, ...

The company is recalling one lot of 25% Dextrose injection after particulate matter was found within an internal sample syringe. On April 21, 2017 FDA announced that Hospira is voluntarily recalling ...